I would really like to hear more about temcell too. Given its msbs only earner RN, it would be interesting to see how they are managing the dependency relationship as an indicator of how they would do so in future commercial agreements.
A very risky position to have tinsimepyait back and "hope" your business is viable based on the work of another company....
Cell Therapy News/Articles, page-38
-
- There are more pages in this discussion • 17,871 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
0.025(2.63%) |
Mkt cap ! $1.098B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 98.0¢ | 93.5¢ | $2.475M | 2.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 61806 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 157591 | 18 |
View Market Depth
| Last trade - 14.23pm 12/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |